FDA Appropriations
This article was originally published in The Pink Sheet Daily
Executive Summary
The Senate Appropriations/Agriculture Subcommittee marked up an FDA appropriations bill June 21 that would provide $1.484 bil. in non-user fee funding to the agency in fiscal year 2006
You may also be interested in...
House Committee Adds $5.9 Mil. To FDA Budget For Drug Safety, Ad Review
The Appropriations Committee unanimously endorses a managers’ amendment that would provide FDA with an additional $5 mil. for “highest priority drug safety needs” and $884,000 for ad review division staff in fiscal year 2006.
Cancer-Genomics Firm Quanticel Debuts With Close Ties To Celgene, And An Exit In Mind
Celgene will get exclusive use of Quanticel's single-cell genomic analysis to tweak its clinical pipeline, and it also has exclusive options to acquire the venture-backed start-up.
One Trial Plus Supportive Evidence Is Enough For Hospital-, Ventilator-Acquired Pneumonia Indication, Panel Says
Anti-Infective Drugs Advisory Committee members viewed one-trial as practical means of gaining efficacy data.